Campbell & Co Investment Adviser’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
Other funds holding INSP
DM
VPM
VCM
Campbell & Co Investment Adviser's INSP Position: Q1 2026 in Review
Campbell & Co Investment Adviser reduced its Inspire Medical Systems (INSP) stake by 20% in Q1 2026, selling an estimated $129K and leaving 7,380 shares worth $381K. The position accounts for 0.02% of the portfolio, ranked #820.
Campbell & Co Investment Adviser first reported a position in INSP in Q3 2021 and has held it in 16 quarters since. The position peaked at $2.21M in Q3 2023. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.
- Campbell & Co Investment Adviser held 7,380 shares of Inspire Medical Systems worth $381K as of Q1 2026.
- Campbell & Co Investment Adviser sold 1,840 Inspire Medical Systems shares in Q1 2026, an estimated $129K.
- Inspire Medical Systems made up 0.02% of Campbell & Co Investment Adviser's portfolio in Q1 2026, its #820 holding.
- Campbell & Co Investment Adviser first reported a position in Inspire Medical Systems in Q3 2021 and has held it in 16 quarters since.
- Campbell & Co Investment Adviser's Inspire Medical Systems position peaked at $2.21M in Q3 2023.
- 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.